Literature DB >> 19694420

Globin monoadducts and cross-links provide evidence for the presence of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide, chlorothioketene, and 2-chlorothionoacetyl chloride in the circulation in rats administered S-(1,2-dichlorovinyl)-L-cysteine.

Nella Barshteyn1, Adnan A Elfarra.   

Abstract

S-(1,2-Dichlorovinyl)-L-cysteine (DCVC), a mutagenic and nephrotoxic metabolite of trichloroethylene, is bioactivated to S-(1,2-dichlorovinyl)-L-cysteine sulfoxide (DCVCS) and chlorothioketene and/or 2-chlorothionoacetyl chloride by cysteine conjugate S-oxidase (S-oxidase) and cysteine conjugate beta-lyase (beta-lyase), respectively. Previously, we identified DCVCS-globin monoadducts and cross-links upon treating rats with DCVCS or incubating erythrocytes with DCVCS. In this study, the formation of DCVC-derived reactive intermediates was investigated after rats were given a single (230 or 460 micromol/kg, i.p.) or multiple (3 or 30 micromol/kg daily for 5 days) DCVC doses. LC/ESI/MS of trypsin-digested globin peptides revealed both S-oxidase and beta-lyase-derived globin monoadducts and cross-links consistent with in vivo DCVC bioactivation by both pathways. MS/MS analyses of trypsin-digested fractions of globin from one of the rats treated with multiple 30 micromol/kg DCVC doses led to identification of beta-lyase-derived monoadducts on both Cys93 and Cys125 of the beta-chains. While rats dosed with the 230 micromol/kg DCVC dose exhibited beta-lyase-dependent monoadducts and cross-links only (four out of four rats), rats given the 460 micromol/kg DCVC dose (two out of four) and rats administered the multiple DCVC doses (two out of four) exhibited both beta-lyase- and S-oxidase-derived monoadducts and cross-links. Because previous incubations of erythrocytes with DCVC did not result in detection of DCVCS-derived monoadducts or cross-links and had only resulted in detection of beta-lyase-derived monoadducts and cross-links, the DCVCS-globin monoadducts and cross-links detected in this study are likely the result of DCVC bioactivation outside the circulation and subsequent translocation of DCVCS and N-acetylated DCVCS into the erythrocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694420      PMCID: PMC2749881          DOI: 10.1021/tx900219x

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  53 in total

1.  ON THE DISSOCIATION OF NORMAL ADULT HUMAN HEMOGLOBIN.

Authors:  G GUIDOTTI; W KONIGSBERG; L C CRAIG
Journal:  Proc Natl Acad Sci U S A       Date:  1963-10       Impact factor: 11.205

2.  Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons.

Authors:  Richard J Albertini; Radim J Sram; Pamela M Vacek; Jeremiah Lynch; Pavel Rossner; Janice A Nicklas; Jake D McDonald; Gunnar Boysen; Nadia Georgieva; James A Swenberg
Journal:  Chem Biol Interact       Date:  2006-07-26       Impact factor: 5.192

Review 3.  Cytochrome P450s and other enzymes in drug metabolism and toxicity.

Authors:  F Peter Guengerich
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

4.  Biomarkers of intermediate endpoints in environmental and occupational health.

Authors:  Lisbeth E Knudsen; Ase M Hansen
Journal:  Int J Hyg Environ Health       Date:  2007-02-23       Impact factor: 5.840

5.  Quantitative analysis of FMO gene mRNA levels in human tissues.

Authors:  Jun Zhang; John R Cashman
Journal:  Drug Metab Dispos       Date:  2005-09-23       Impact factor: 3.922

6.  Dose-dependent protein adduct formation in kidney, liver, and blood of rats and in human blood after perchloroethene inhalation.

Authors:  A Pähler; J Parker; W Dekant
Journal:  Toxicol Sci       Date:  1999-03       Impact factor: 4.849

7.  Diabetic mice are protected from normally lethal nephrotoxicity of S-1,2-dichlorovinyl-L-cysteine (DCVC): role of nephrogenic tissue repair.

Authors:  Ankur V Dnyanmote; Sharmilee P Sawant; Edward A Lock; John R Latendresse; Alan A Warbritton; Harihara M Mehendale
Journal:  Toxicol Appl Pharmacol       Date:  2005-08-25       Impact factor: 4.219

8.  Formation of three N-acetyl-L-cysteine monoadducts and one diadduct by the reaction of S-(1,2-dichlorovinyl)-L-cysteine sulfoxide with N-acetyl-L-cysteine at physiological conditions: chemical mechanisms and toxicological implications.

Authors:  Nella Barshteyn; Adnan A Elfarra
Journal:  Chem Res Toxicol       Date:  2007-09-25       Impact factor: 3.739

9.  Identification of S-(1,2-dichlorovinyl)glutathione in the blood of human volunteers exposed to trichloroethylene.

Authors:  L H Lash; D A Putt; W T Brashear; R Abbas; J C Parker; J W Fisher
Journal:  J Toxicol Environ Health A       Date:  1999-01-08

Review 10.  Cysteine S-conjugate beta-lyases.

Authors:  A J L Cooper; J T Pinto
Journal:  Amino Acids       Date:  2006-02-06       Impact factor: 3.520

View more
  5 in total

1.  Mutagenicity of the cysteine S-conjugate sulfoxides of trichloroethylene and tetrachloroethylene in the Ames test.

Authors:  Roy M Irving; Adnan A Elfarra
Journal:  Toxicology       Date:  2013-02-13       Impact factor: 4.221

2.  N-biotinyl-S-(1,2-dichlorovinyl)-L-cysteine sulfoxide as a potential model for S-(1,2-dichlorovinyl)-L-cysteine sulfoxide: characterization of stability and reactivity with glutathione and kidney proteins in vitro.

Authors:  Roy M Irving; Mark S Brownfield; Adnan A Elfarra
Journal:  Chem Res Toxicol       Date:  2011-10-25       Impact factor: 3.739

Review 3.  Role of reactive metabolites in the circulation in extrahepatic toxicity.

Authors:  Roy M Irving; Adnan A Elfarra
Journal:  Expert Opin Drug Metab Toxicol       Date:  2012-06-11       Impact factor: 4.481

4.  Characterization of the chemical reactivity and nephrotoxicity of N-acetyl-S-(1,2-dichlorovinyl)-L-cysteine sulfoxide, a potential reactive metabolite of trichloroethylene.

Authors:  Roy M Irving; Marie E Pinkerton; Adnan A Elfarra
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-16       Impact factor: 4.219

Review 5.  Toxicity mechanism-based prodrugs: glutathione-dependent bioactivation as a strategy for anticancer prodrug design.

Authors:  Xin-Yu Zhang; Adnan A Elfarra
Journal:  Expert Opin Drug Discov       Date:  2018-08-13       Impact factor: 6.098

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.